| Gabrielle Yvonne Klein, LPN | |
|
56-119 Pualalea St, Kahuku, HI 96731-2052 | |
| (808) 293-9231 | |
| Not Available |
| Full Name | Gabrielle Yvonne Klein |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 56-119 Pualalea St, Kahuku, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992494322 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Gabrielle Yvonne Klein, LPN 95-227 Waikalani Dr Apt A1205, Mililani, HI 96789-3543 Ph: (808) 425-2658 | Gabrielle Yvonne Klein, LPN 56-119 Pualalea St, Kahuku, HI 96731-2052 Ph: (808) 293-9231 |
News Archive
Helix BioPharma Corp. today announced progress updates for its ongoing Topical Interferon Alpha-2b and L-DOS47 product development programs following pre-investigational new drug ("pre-IND") meetings with the U.S. Food and Drug Administration ("FDA").
The presence of collagen in the tumor microenvironment, essentially where the tumor lives, can be either good or bad according to Constance Brinckerhoff, PhD who led the Dartmouth team's reporting of "The BRAFV600E inhibitor, PLX4032, increases type 1 collagen synthesis in melanoma cells," in Matrix Biology Journal.
Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have found a practical way to induce a strong and broad immunity to the dengue virus based on proof-of-concept studies in mice.
Evidence-Based Approaches to Population Health and Family Practice is the theme of the new issue of Family Medicine and Community Health, an international peer reviewed medical journal with editorial offices in China and the U.S. The Summer 2015 issue includes six original research articles, two educational research articles and two systematic reviews addressing various topics in evidence based population health and patient care.
Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
› Verified 5 days ago